US Stock MarketDetailed Quotes

INNMF AMPLIA THERAPEUTICS LTD

Watchlist
  • 0.060
  • -0.010-14.29%
15min DelayClose Nov 13 09:56 ET
21.49MMarket Cap-4285P/E (TTM)

AMPLIA THERAPEUTICS LTD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 30, 2024
(FY)Mar 30, 2023
(FY)Mar 30, 2022
(FY)Mar 30, 2021
(FY)Mar 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities
96.19%-2.23K
-119.30%-58.43K
-398.26%-26.64K
-5.35K
Net PPE purchase and sale
87.37%-2.23K
-22.42%-17.63K
-169.35%-14.4K
---5.35K
----
Net other investing changes
----
-233.28%-40.79K
---12.24K
----
----
Cash from discontinued investing activities
Investing cash flow
96.19%-2.23K
-119.30%-58.43K
-398.26%-26.64K
---5.35K
----
Financing cash flow
Cash flow from continuing financing activities
-817.84%-772.98K
-100.49%-84.22K
369.22%17.19M
87.10%3.66M
1.96M
Net issuance payments of debt
---633K
----
--2.1M
----
----
Net common stock issuance
-98.86%241
-99.86%21.23K
311.90%15.09M
87.10%3.66M
--1.96M
Net other financing activities
-23.75%-80K
---64.65K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-817.84%-772.98K
-100.49%-84.22K
369.22%17.19M
87.10%3.66M
--1.96M
Net cash flow
Beginning cash position
-36.64%9.26M
690.33%14.61M
66.81%1.85M
-10.70%1.11M
--1.24M
Current changes in cash
-8.65%-5.9M
-142.57%-5.43M
1,620.41%12.76M
670.33%741.7K
---130.05K
Effect of exchange rate changes
-61.43%31.02K
43,108.56%80.43K
86.75%-187
48.62%-1.41K
---2.75K
End cash Position
-63.43%3.39M
-36.64%9.26M
690.33%14.61M
66.81%1.85M
--1.11M
Free cash flow
3.35%-5.13M
-20.17%-5.31M
-51.16%-4.42M
-39.93%-2.92M
---2.09M
Currency Unit
AUD
AUD
AUD
AUD
AUD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Mar 30, 2024(FY)Mar 30, 2023(FY)Mar 30, 2022(FY)Mar 30, 2021(FY)Mar 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities 96.19%-2.23K-119.30%-58.43K-398.26%-26.64K-5.35K
Net PPE purchase and sale 87.37%-2.23K-22.42%-17.63K-169.35%-14.4K---5.35K----
Net other investing changes -----233.28%-40.79K---12.24K--------
Cash from discontinued investing activities
Investing cash flow 96.19%-2.23K-119.30%-58.43K-398.26%-26.64K---5.35K----
Financing cash flow
Cash flow from continuing financing activities -817.84%-772.98K-100.49%-84.22K369.22%17.19M87.10%3.66M1.96M
Net issuance payments of debt ---633K------2.1M--------
Net common stock issuance -98.86%241-99.86%21.23K311.90%15.09M87.10%3.66M--1.96M
Net other financing activities -23.75%-80K---64.65K------------
Cash from discontinued financing activities
Financing cash flow -817.84%-772.98K-100.49%-84.22K369.22%17.19M87.10%3.66M--1.96M
Net cash flow
Beginning cash position -36.64%9.26M690.33%14.61M66.81%1.85M-10.70%1.11M--1.24M
Current changes in cash -8.65%-5.9M-142.57%-5.43M1,620.41%12.76M670.33%741.7K---130.05K
Effect of exchange rate changes -61.43%31.02K43,108.56%80.43K86.75%-18748.62%-1.41K---2.75K
End cash Position -63.43%3.39M-36.64%9.26M690.33%14.61M66.81%1.85M--1.11M
Free cash flow 3.35%-5.13M-20.17%-5.31M-51.16%-4.42M-39.93%-2.92M---2.09M
Currency Unit AUDAUDAUDAUDAUD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data